Current Status and Outcomes of Iliac Artery Endovascular Intervention

Vladimir Lakhter; Vikas Aggarwal

doi:10.1016/j.iccl.2016.12.001

Current Status and Outcomes of Iliac Artery Endovascular Intervention

Interv Cardiol Clin. 2017 Apr;6(2):167-180. doi: 10.1016/j.iccl.2016.12.001. Epub 2017 Jan 27.

Authors

Vladimir Lakhter¹, Vikas Aggarwal²

Affiliations

¹ Division of Cardiology, Department of Internal Medicine, Section of Interventional Cardiology, Lewis Katz School of Medicine, Temple University, 3401 North Broad Street, C945, Philadelphia, PA 19140, USA.
² Division of Cardiology, Department of Internal Medicine, Section of Interventional Cardiology, Lewis Katz School of Medicine, Temple University, 3401 North Broad Street, C945, Philadelphia, PA 19140, USA. Electronic address: vikas.aggarwal@tuhs.temple.edu.

PMID: 28257765
DOI: 10.1016/j.iccl.2016.12.001

Abstract

Aortoiliac occlusive disease (AIOD) is widely prevalent and leads to significant limitations in patient quality of life. All patients with aortoiliac occlusive disease should be managed with approved medical therapies in addition to a supervised exercise program. Persistence of significant symptoms despite noninvasive therapy should prompt further management with endovascular revascularization. Although patients with the most complex cases of AIOD anatomy may ultimately require surgery, advances in endovascular techniques have made it possible to treat most of these patients with AIOD using an endovascular-first approach.

Keywords: Endovascular intervention; Iliac artery intervention; Iliac stent; Peripheral artery disease.

Publication types

Review

MeSH terms

Arterial Occlusive Diseases / surgery*
Endovascular Procedures / methods*
Humans
Iliac Artery / surgery*
Stents*
Treatment Outcome